Enrolling by invitationNCT04708535

Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin Resistance

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Stanford University
Principal Investigator
Tracey McLaughlin, MD
Stanford University
Enrollment
50 target
Eligibility
30-65 years · All sexes
Timeline
20172025

Study locations (1)

Collaborators

American Heart Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04708535 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials